Predictability of PSA failure in prostate cancer by computerized cytometric assessment of tumoral cell proliferation - differences between image analysis and flow cytometry and clinical implications

Author： Diaz J.I.   Mora L.B.   Austin P.F.   Muro-Cacho C.A.   Cantor A.B.   Nicosia S.V.   Pow-Sang J.M.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.53, Iss.5, 1999-05, pp. : 931-938

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after intervention

By Jani A.B.   Chen M.-H.   Vaida F.   Ignacio L.   Awan A.   Weichselbaum R.R.   Vijayakumar S.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 700-705

Elsevier

Access to resources Recommend Favorite

Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis

By Bratt O.   Anderson H.   Bak-Jensen E.   Baldetorp B.   Lundgren R.  

Urology, Vol. 47, Iss. 2, 1996-02 ,pp. : 218-224

Elsevier

Access to resources Recommend Favorite

PSA Changes in Early Prostate Cancer: Implications for Patient Management

By See W.A.  

European Urology Supplements, Vol. 1, Iss. 5, 2002-08 ,pp. : 17-23

Elsevier

Access to resources Recommend Favorite

Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA - what's new in 1997

By Kalish L.A.   McKinlay J.B.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1022-1027

Elsevier

Access to resources Recommend Favorite

PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

By Fang J.   Metter E.J.   Landis P.   Carter H.B.  

Urology, Vol. 59, Iss. 6, 2002-06 ,pp. : 889-893

Elsevier

Access to resources Recommend Favorite